Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 9

1.

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC.

Mulligan LM, Eng C, Healey CS, Clayton D, Kwok JB, Gardner E, Ponder MA, Frilling A, Jackson CE, Lehnert H, et al.

Nat Genet. 1994 Jan;6(1):70-4.

PMID:
7907913
2.

Evidence of MEN-2 in the original description of classic pheochromocytoma.

Neumann HP, Vortmeyer A, Schmidt D, Werner M, Erlic Z, Cascon A, Bausch B, Januszewicz A, Eng C.

N Engl J Med. 2007 Sep 27;357(13):1311-5.

3.

Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients.

Cascón A, Inglada-Pérez L, Comino-Méndez I, de Cubas AA, Letón R, Mora J, Marazuela M, Galofré JC, Quesada-Charneco M, Robledo M.

Endocr Relat Cancer. 2013 May 30;20(3):L1-6. doi: 10.1530/ERC-12-0339. Print 2013 Jun. No abstract available.

PMID:
23404858
4.

Surgery in MEN 2A Patients Older Than 5 Years with Micro-MTC: Outcome at Long-term Follow-up.

Tonelli F, Giudici F, Marcucci T, Cavalli T, Spini S, Gheri RG, Brandi ML.

Otolaryngol Head Neck Surg. 2016 Nov;155(5):787-789. Epub 2016 Jul 12.

PMID:
27406704
5.

RET activation by germline MEN2A and MEN2B mutations.

Borrello MG, Smith DP, Pasini B, Bongarzone I, Greco A, Lorenzo MJ, Arighi E, Miranda C, Eng C, Alberti L, et al.

Oncogene. 1995 Dec 7;11(11):2419-27.

PMID:
8570194
6.

Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.

Milos IN, Frank-Raue K, Wohllk N, Maia AL, Pusiol E, Patocs A, Robledo M, Biarnes J, Barontini M, Links TP, de Groot JW, Dvorakova S, Peczkowska M, Rybicki LA, Sullivan M, Raue F, Zosin I, Eng C, Neumann HP.

Endocr Relat Cancer. 2008 Dec;15(4):1035-41. doi: 10.1677/ERC-08-0105. Epub 2008 Sep 15.

PMID:
18794325
7.

Early onset of medullary thyroid carcinoma in a kindred with multiple endocrine neoplasia type iia associated with cutaneous lichen amyloidosis.

Lemos MC, Carrilho F, Rodrigues FJ, Santos P, Carvalheiro M, Ruas MA, Regateiro FJ.

Endocr Pract. 2002 Jan-Feb;8(1):19-22.

PMID:
11939755
8.

Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.

Lips CJ, Landsvater RM, Höppener JW, Geerdink RA, Blijham G, van Veen JM, van Gils AP, de Wit MJ, Zewald RA, Berends MJ, et al.

N Engl J Med. 1994 Sep 29;331(13):828-35.

9.

RET codon 634 mutations in multiple endocrine neoplasia type 2: variable clinical features and clinical outcome.

Puñales MK, Graf H, Gross JL, Maia AL.

J Clin Endocrinol Metab. 2003 Jun;88(6):2644-9.

PMID:
12788868

Supplemental Content

Support Center